APO Research
Talk to an analyst

APO RESEARCH · REPORT

Amiodarone Injection

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Amiodarone Injection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

2 January 2026198 pages

Choose your research edition.

Industry ResearchAmiodarone Injection Industry Research Report 2026122 pages · $2,950 USDIndustry Growth & TrendsGlobal Amiodarone Injection Industry Growth and Trends Forecast to 2032106 pages · $3,450 USDMarket StructureGlobal Amiodarone Injection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Amiodarone Injection Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Amiodarone Injection Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Amiodarone Injection market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Amiodarone Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Amiodarone Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Amiodarone Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Amiodarone Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Amiodarone Injection include AuroMedics, Bioniche Pharma, Hikma, Prism Pharmaceutical, Sagent, Baxter, Fangming Pharmaceutical Group, Fresenius Kabi and Mylan, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Amiodarone Injection market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Amiodarone Injection and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Amiodarone Injection sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Amiodarone Injection market size, projected growth trends, production technologies, key applications, and end-use industries.

Amiodarone Injection Segment by Company

AuroMedics

Bioniche Pharma

Hikma

Prism Pharmaceutical

Sagent

Baxter

Fangming Pharmaceutical Group

Fresenius Kabi

Mylan

Sanofi

Amiodarone Injection Segment by Type

15mg/ml

50mg/ml

Amiodarone Injection Segment by Application

Clinics

Hospital

Recovery Center

Amiodarone Injection Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Amiodarone Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Amiodarone Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Amiodarone Injection.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Amiodarone Injection market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Amiodarone Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Amiodarone Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Amiodarone Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Amiodarone Injection Industry Trends Table 2. Amiodarone Injection Industry Drivers Table 3. Amiodarone Injection Industry Opportunities and Challenges Table 4. Amiodarone Injection Industry Restraints Table 5. Global Amiodarone Injection Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Amiodarone Injection Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Amiodarone Injection Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Amiodarone Injection Sales Market Share by Manufacturers Table 9. Global Amiodarone Injection Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Amiodarone Injection Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Amiodarone Injection Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Amiodarone Injection Manufacturers, Product Type & Application Table 13. Global Amiodarone Injection Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Amiodarone Injection by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of 15mg/ml Table 17. Major Manufacturers of 50mg/ml Table 18. Global Amiodarone Injection Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 19. Global Amiodarone Injection Sales by Type (2021-2026) & (K Units) Table 20. Global Amiodarone Injection Sales by Type (2027-2032) & (K Units) Table 21. Global Amiodarone Injection Sales Market Share by Type (2021-2026) Table 22. Global Amiodarone Injection Sales Market Share by Type (2027-2032) Table 23. Global Amiodarone Injection Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 24. Global Amiodarone Injection Revenue by Type (2021-2026) & (K Units) Table 25. Global Amiodarone Injection Revenue by Type (2027-2032) & (K Units) Table 26. Global Amiodarone Injection Revenue Market Share by Type (2021-2026) Table 27. Global Amiodarone Injection Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Clinics Table 29. Major Manufacturers of Hospital Table 30. Major Manufacturers of Recovery Center Table 31. Global Amiodarone Injection Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 32. Global Amiodarone Injection Sales by Application (2021-2026) & (K Units) Table 33. Global Amiodarone Injection Sales by Application (2027-2032) & (K Units) Table 34. Global Amiodarone Injection Sales Market Share by Application (2021-2026) Table 35. Global Amiodarone Injection Sales Market Share by Application (2027-2032) Table 36. Global Amiodarone Injection Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 37. Global Amiodarone Injection Revenue by Application (2021-2026) & (K Units) Table 38. Global Amiodarone Injection Revenue by Application (2027-2032) & (K Units) Table 39. Global Amiodarone Injection Revenue Market Share by Application (2021-2026) Table 40. Global Amiodarone Injection Revenue Market Share by Application (2027-2032) Table 41. Global Amiodarone Injection Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 42. Global Amiodarone Injection Sales by Region (2021-2026) & (K Units) Table 43. Global Amiodarone Injection Sales Market Share by Region (2021-2026) Table 44. Global Amiodarone Injection Sales Forecasted by Region (2027-2032) & (K Units) Table 45. Global Amiodarone Injection Sales Forecasted Market Share by Region (2027-2032) Table 46. North America Amiodarone Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 47. North America Amiodarone Injection Sales by Country (2021-2026) & (K Units) Table 48. North America Amiodarone Injection Sales by Country (2027-2032) & (K Units) Table 49. Europe Amiodarone Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 50. Europe Amiodarone Injection Sales by Country (2021-2026) & (K Units) Table 51. Europe Amiodarone Injection Sales by Country (2027-2032) & (K Units) Table 52. Asia Pacific Amiodarone Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 53. Asia Pacific Amiodarone Injection Sales by Country (2021-2026) & (K Units) Table 54. Asia Pacific Amiodarone Injection Sales by Country (2027-2032) & (K Units) Table 55. South America, Middle East and Africa Amiodarone Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 56. South America, Middle East and Africa Amiodarone Injection Sales by Country (2021-2026) & (K Units) Table 57. South America, Middle East and Africa Amiodarone Injection Sales by Country (2027-2032) & (K Units) Table 58. Global Amiodarone Injection Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Amiodarone Injection Revenue by Region (2021-2026) & (US$ Million) Table 60. Global Amiodarone Injection Revenue by Region (2027-2032) & (US$ Million) Table 61. Global Amiodarone Injection Revenue Market Share by Region (2021-2026) Table 62. Global Amiodarone Injection Revenue Market Share by Region (2027-2032) Table 63. AuroMedics Company Information Table 64. AuroMedics Business Overview Table 65. AuroMedics Amiodarone Injection Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. AuroMedics Amiodarone Injection Product Portfolio Table 67. AuroMedics Recent Development Table 68. Bioniche Pharma Company Information Table 69. Bioniche Pharma Business Overview Table 70. Bioniche Pharma Amiodarone Injection Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Bioniche Pharma Amiodarone Injection Product Portfolio Table 72. Bioniche Pharma Recent Development Table 73. Hikma Company Information Table 74. Hikma Business Overview Table 75. Hikma Amiodarone Injection Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Hikma Amiodarone Injection Product Portfolio Table 77. Hikma Recent Development Table 78. Prism Pharmaceutical Company Information Table 79. Prism Pharmaceutical Business Overview Table 80. Prism Pharmaceutical Amiodarone Injection Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Prism Pharmaceutical Amiodarone Injection Product Portfolio Table 82. Prism Pharmaceutical Recent Development Table 83. Sagent Company Information Table 84. Sagent Business Overview Table 85. Sagent Amiodarone Injection Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Sagent Amiodarone Injection Product Portfolio Table 87. Sagent Recent Development Table 88. Baxter Company Information Table 89. Baxter Business Overview Table 90. Baxter Amiodarone Injection Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. Baxter Amiodarone Injection Product Portfolio Table 92. Baxter Recent Development Table 93. Fangming Pharmaceutical Group Company Information Table 94. Fangming Pharmaceutical Group Business Overview Table 95. Fangming Pharmaceutical Group Amiodarone Injection Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 96. Fangming Pharmaceutical Group Amiodarone Injection Product Portfolio Table 97. Fangming Pharmaceutical Group Recent Development Table 98. Fresenius Kabi Company Information Table 99. Fresenius Kabi Business Overview Table 100. Fresenius Kabi Amiodarone Injection Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 101. Fresenius Kabi Amiodarone Injection Product Portfolio Table 102. Fresenius Kabi Recent Development Table 103. Mylan Company Information Table 104. Mylan Business Overview Table 105. Mylan Amiodarone Injection Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 106. Mylan Amiodarone Injection Product Portfolio Table 107. Mylan Recent Development Table 108. Sanofi Company Information Table 109. Sanofi Business Overview Table 110. Sanofi Amiodarone Injection Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 111. Sanofi Amiodarone Injection Product Portfolio Table 112. Sanofi Recent Development Table 113. Key Raw Materials Table 114. Raw Materials Key Suppliers Table 115. Amiodarone Injection Distributors List Table 116. Amiodarone Injection Customers List Table 117. Research Programs/Design for This Report Table 118. Authors List of This Report Table 119. Secondary Sources Table 120. Primary Sources List of Figures Figure 1. Amiodarone Injection Product Image Figure 2. Global Amiodarone Injection Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Amiodarone Injection Market Size (2021-2032) & (US$ Million) Figure 4. Global Amiodarone Injection Sales (2021-2032) & (K Units) Figure 5. Global Amiodarone Injection Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Amiodarone Injection Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. 15mg/ml Image Figure 9. 50mg/ml Image Figure 10. Global Amiodarone Injection Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 11. Global Amiodarone Injection Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Amiodarone Injection Sales Market Share by Type (2021-2032) Figure 13. Global Amiodarone Injection Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 14. Global Amiodarone Injection Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Amiodarone Injection Revenue Market Share by Type (2021-2032) Figure 16. Clinics Image Figure 17. Hospital Image Figure 18. Recovery Center Image Figure 19. Global Amiodarone Injection Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 20. Global Amiodarone Injection Sales Market Share 2021 VS 2025 VS 2032 Figure 21. Global Amiodarone Injection Sales Market Share by Application (2021-2032) Figure 22. Global Amiodarone Injection Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 23. Global Amiodarone Injection Revenue Market Share 2021 VS 2025 VS 2032 Figure 24. Global Amiodarone Injection Revenue Market Share by Application (2021-2032) Figure 25. North America Amiodarone Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 26. North America Amiodarone Injection Sales Market Share by Country (2021-2032) Figure 27. U.S. Amiodarone Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 28. Canada Amiodarone Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 29. Mexico Amiodarone Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Europe Amiodarone Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Europe Amiodarone Injection Sales Market Share by Country (2021-2032) Figure 32. Germany Amiodarone Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 33. France Amiodarone Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 34. U.K. Amiodarone Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 35. Italy Amiodarone Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Netherlands Amiodarone Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Asia Pacific Amiodarone Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Asia Pacific Amiodarone Injection Sales Market Share by Country (2021-2032) Figure 39. China Amiodarone Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 40. Japan Amiodarone Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 41. South Korea Amiodarone Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 42. Southeast Asia Amiodarone Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 43. India Amiodarone Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 44. Australia Amiodarone Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 45. South America, Middle East and Africa Amiodarone Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 46. South America, Middle East and Africa Amiodarone Injection Sales Market Share by Country (2021-2032) Figure 47. Brazil Amiodarone Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 48. South Africa Amiodarone Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 49. Saudi Arabia Amiodarone Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 50. Turkey Amiodarone Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 51. Argentina Amiodarone Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 52. UAE Amiodarone Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Egypt Amiodarone Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Chile Amiodarone Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Global Amiodarone Injection Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Global Amiodarone Injection Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 57. North America Amiodarone Injection Revenue (2021-2032) & (US$ Million) Figure 58. North America Amiodarone Injection Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe Amiodarone Injection Revenue (2021-2032) & (US$ Million) Figure 60. Europe Amiodarone Injection Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Amiodarone Injection Revenue (2021-2032) & (US$ Million) Figure 62. Asia-Pacific Amiodarone Injection Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. South America, Middle East and Africa Amiodarone Injection Revenue (2021-2032) & (US$ Million) Figure 64. South America, Middle East and Africa Amiodarone Injection Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Amiodarone Injection Value Chain Figure 66. Manufacturing Cost Structure Figure 67. Amiodarone Injection Production Mode & Process Figure 68. Direct Comparison with Distribution Share Figure 69. Distributors Profiles Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • 15mg/ml
  • 50mg/ml
Applications
  • Clinics
  • Hospital
  • Recovery Center
Companies covered
  • AuroMedics
  • Bioniche Pharma
  • Hikma
  • Prism Pharmaceutical
  • Sagent
  • Baxter
  • Fangming Pharmaceutical Group
  • Fresenius Kabi
  • Mylan
  • Sanofi

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Amiodarone Injection Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Amiodarone Injection Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Amiodarone Injection Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Amiodarone Injection Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Amiodarone Injection Market Dynamics
  1. 2.1 Amiodarone Injection Industry Trends
  2. 2.2 Amiodarone Injection Industry Drivers
  3. 2.3 Amiodarone Injection Industry Opportunities and Challenges
  4. 2.4 Amiodarone Injection Industry Restraints
3 Amiodarone Injection Market by Manufacturers
  1. 3.1 Global Amiodarone Injection Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Amiodarone Injection Sales by Manufacturers (2021-2026)
  3. 3.3 Global Amiodarone Injection Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Amiodarone Injection Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Amiodarone Injection Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Amiodarone Injection Manufacturers, Product Type & Application
  7. 3.7 Global Amiodarone Injection Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Amiodarone Injection Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Amiodarone Injection Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Amiodarone Injection Tier 1, Tier 2, and Tier 3
4 Amiodarone Injection Market by Type
  1. 4.1 Amiodarone Injection Type Introduction
  2. 4.1.1 15mg/ml
  3. 4.1.2 50mg/ml
  4. 4.2 Global Amiodarone Injection Sales by Type
  5. 4.2.1 Global Amiodarone Injection Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Amiodarone Injection Sales by Type (2021-2032)
  7. 4.2.3 Global Amiodarone Injection Sales Market Share by Type (2021-2032)
  8. 4.3 Global Amiodarone Injection Revenue by Type
  9. 4.3.1 Global Amiodarone Injection Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Amiodarone Injection Revenue by Type (2021-2032)
  11. 4.3.3 Global Amiodarone Injection Revenue Market Share by Type (2021-2032)
5 Amiodarone Injection Market by Application
  1. 5.1 Amiodarone Injection Application Introduction
  2. 5.1.1 Clinics
  3. 5.1.2 Hospital
  4. 5.1.3 Recovery Center
  5. 5.2 Global Amiodarone Injection Sales by Application
  6. 5.2.1 Global Amiodarone Injection Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Amiodarone Injection Sales by Application (2021-2032)
  8. 5.2.3 Global Amiodarone Injection Sales Market Share by Application (2021-2032)
  9. 5.3 Global Amiodarone Injection Revenue by Application
  10. 5.3.1 Global Amiodarone Injection Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Amiodarone Injection Revenue by Application (2021-2032)
  12. 5.3.3 Global Amiodarone Injection Revenue Market Share by Application (2021-2032)
6 Global Amiodarone Injection Sales by Region
  1. 6.1 Global Amiodarone Injection Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Amiodarone Injection Sales by Region (2021-2032)
  3. 6.2.1 Global Amiodarone Injection Sales by Region (2021-2026)
  4. 6.2.2 Global Amiodarone Injection Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Amiodarone Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Amiodarone Injection Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Amiodarone Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Amiodarone Injection Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Amiodarone Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Amiodarone Injection Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Amiodarone Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Amiodarone Injection Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Amiodarone Injection Revenue by Region
  1. 7.1 Global Amiodarone Injection Revenue by Region
  2. 7.1.1 Global Amiodarone Injection Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Amiodarone Injection Revenue by Region (2021-2026)
  4. 7.1.3 Global Amiodarone Injection Revenue by Region (2027-2032)
  5. 7.1.4 Global Amiodarone Injection Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Amiodarone Injection Revenue (2021-2032)
  8. 7.2.2 North America Amiodarone Injection Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Amiodarone Injection Revenue (2021-2032)
  11. 7.3.2 Europe Amiodarone Injection Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Amiodarone Injection Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Amiodarone Injection Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Amiodarone Injection Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Amiodarone Injection Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 AuroMedics
  2. 8.1.1 AuroMedics Company Information
  3. 8.1.2 AuroMedics Business Overview
  4. 8.1.3 AuroMedics Amiodarone Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 AuroMedics Amiodarone Injection Product Portfolio
  6. 8.1.5 AuroMedics Recent Developments
  7. 8.2 Bioniche Pharma
  8. 8.2.1 Bioniche Pharma Company Information
  9. 8.2.2 Bioniche Pharma Business Overview
  10. 8.2.3 Bioniche Pharma Amiodarone Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Bioniche Pharma Amiodarone Injection Product Portfolio
  12. 8.2.5 Bioniche Pharma Recent Developments
  13. 8.3 Hikma
  14. 8.3.1 Hikma Company Information
  15. 8.3.2 Hikma Business Overview
  16. 8.3.3 Hikma Amiodarone Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Hikma Amiodarone Injection Product Portfolio
  18. 8.3.5 Hikma Recent Developments
  19. 8.4 Prism Pharmaceutical
  20. 8.4.1 Prism Pharmaceutical Company Information
  21. 8.4.2 Prism Pharmaceutical Business Overview
  22. 8.4.3 Prism Pharmaceutical Amiodarone Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Prism Pharmaceutical Amiodarone Injection Product Portfolio
  24. 8.4.5 Prism Pharmaceutical Recent Developments
  25. 8.5 Sagent
  26. 8.5.1 Sagent Company Information
  27. 8.5.2 Sagent Business Overview
  28. 8.5.3 Sagent Amiodarone Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Sagent Amiodarone Injection Product Portfolio
  30. 8.5.5 Sagent Recent Developments
  31. 8.6 Baxter
  32. 8.6.1 Baxter Company Information
  33. 8.6.2 Baxter Business Overview
  34. 8.6.3 Baxter Amiodarone Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Baxter Amiodarone Injection Product Portfolio
  36. 8.6.5 Baxter Recent Developments
  37. 8.7 Fangming Pharmaceutical Group
  38. 8.7.1 Fangming Pharmaceutical Group Company Information
  39. 8.7.2 Fangming Pharmaceutical Group Business Overview
  40. 8.7.3 Fangming Pharmaceutical Group Amiodarone Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Fangming Pharmaceutical Group Amiodarone Injection Product Portfolio
  42. 8.7.5 Fangming Pharmaceutical Group Recent Developments
  43. 8.8 Fresenius Kabi
  44. 8.8.1 Fresenius Kabi Company Information
  45. 8.8.2 Fresenius Kabi Business Overview
  46. 8.8.3 Fresenius Kabi Amiodarone Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Fresenius Kabi Amiodarone Injection Product Portfolio
  48. 8.8.5 Fresenius Kabi Recent Developments
  49. 8.9 Mylan
  50. 8.9.1 Mylan Company Information
  51. 8.9.2 Mylan Business Overview
  52. 8.9.3 Mylan Amiodarone Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Mylan Amiodarone Injection Product Portfolio
  54. 8.9.5 Mylan Recent Developments
  55. 8.10 Sanofi
  56. 8.10.1 Sanofi Company Information
  57. 8.10.2 Sanofi Business Overview
  58. 8.10.3 Sanofi Amiodarone Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Sanofi Amiodarone Injection Product Portfolio
  60. 8.10.5 Sanofi Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Amiodarone Injection Value Chain Analysis
  2. 9.1.1 Amiodarone Injection Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Amiodarone Injection Production Mode & Process
  6. 9.2 Amiodarone Injection Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Amiodarone Injection Distributors
  9. 9.2.3 Amiodarone Injection Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst